Krystal Biotech Inc (KRYS)

Current ratio

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Total current assets	US$ in thousands	587,909	383,779	442,267	275,058	195,880
Total current liabilities	US$ in thousands	33,094	28,847	25,736	15,452	3,327
Current ratio		17.76	13.30	17.18	17.80	58.88

December 31, 2023 calculation

Current ratio = Total current assets ÷ Total current liabilities
= $587,909K ÷ $33,094K
= 17.76

The current ratio for Krystal Biotech Inc has shown fluctuations over the past five years. As of December 31, 2023, the current ratio stands at 17.76, indicating a significant increase compared to the previous year. This implies that the company's current assets are 17.76 times its current liabilities, suggesting a strong ability to cover short-term obligations.

In 2022, the current ratio was 13.30, showing a slight decrease from the previous year. However, the ratio improved in 2021 to 17.18, demonstrating a healthier liquidity position. The company's liquidity was particularly strong in 2020, with a current ratio of 17.80, indicating ample liquidity to meet short-term liabilities.

Notably, in 2019, the current ratio was exceptionally high at 58.88, indicating a substantial increase in current assets relative to current liabilities. This may have been due to specific events or accounting practices during that period.

Overall, the trend in Krystal Biotech Inc's current ratio suggests variations in the company's liquidity position over the past five years. For a more in-depth analysis, it would be beneficial to consider the composition of current assets and liabilities to better understand the company's liquidity management and financial health.